Comparing two anesthesia techniques for shoulder surgery
Pericapsular Nerve Group Block vs Low Volume Interscalene Brachial Plexus Block for Shoulder Arthroscopy: A Randomized Controlled Trial
This study is testing which anesthesia method, the PENG block or the Interscalene Block, works better for people having shoulder surgery to see how well they manage pain afterwards.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo, Governorate) |
| Trial ID | NCT06208774 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the effectiveness of the Pericapsular Nerve Group (PENG) block versus the Interscalene Block (ISBP) in patients undergoing shoulder arthroscopy. It will assess various outcomes including the incidence of phrenic nerve block, duration of postoperative analgesia, time to first analgesic request, pain scores, and side effects. Patients will be randomly assigned to one of the two groups, and diaphragmatic movement will be evaluated using ultrasound before and after the procedure. The study will be conducted at Cairo University Hospital with a focus on ensuring patient safety and accurate measurement of outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 to 60 scheduled for shoulder arthroscopy with ASA status I or II.
Not a fit: Patients with severe cardiopulmonary disease, coagulopathy, or those on chronic opioid therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management techniques for patients undergoing shoulder surgery.
How similar studies have performed: Previous studies have shown promising results with similar regional anesthesia techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients scheduled for shoulder arthroscopy * American Society of Anesthesiologists (ASA) status I and II * Ages between 18 and 60 years. Exclusion Criteria: * Coagulopathy * Infection at the injection site. * Allergy to local anesthetics * Severe cardiopulmonary disease (≥ASA III) * Diabetic or other neuropathies * Motor disorders * Patients receiving opioids for chronic analgesic therapy. * Inability to comprehend visual analogue scale (VAS).
Where this trial is running
Cairo, Governorate
- Cairo university Hospitals. kasralainy — Cairo, Governorate, Egypt (Recruiting)
Study contacts
- Study coordinator: Nagy malak, MD
- Email: nagymalak1234@gmail.com
- Phone: 01552480258
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.